Cite

HARVARD Citation

    Ma, C. et al. (2022). Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn‐ or metachronous metastatic disease. Prostate. 82 (3), pp. 345-351. [Online]. 
  
Back to record